Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV002513042 | SCV003441526 | uncertain significance | Sphingolipid activator protein 1 deficiency | 2022-03-19 | criteria provided, single submitter | clinical testing | This variant, c.207_209del, results in the deletion of 1 amino acid(s) of the PSAP protein (p.Val70del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs757687480, gnomAD 0.0009%). This variant has been observed in individual(s) with clinical features of combined saposin deficiency (PMID: 15773042). ClinVar contains an entry for this variant (Variation ID: 13369). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| OMIM | RCV000014298 | SCV000034547 | pathogenic | Krabbe disease due to saposin A deficiency | 2005-02-01 | no assertion criteria provided | literature only |